BIO-TECHNE counsel Bohnen acquires 4,420 shares

Q: How many TECH shares did Shane Bohnen acquire?

Shane Bohnen acquired 4,420 common shares on August 15, 2026, as restricted stock units vested.

Q: How many TECH shares did Shane Bohnen deliver or have withheld?

On August 15, 2026, 1,366 common shares were delivered or withheld for payment of exercise price or tax liability at $72.40 per share.

Q: How many of Shane Bohnen’s performance options were forfeited?

11,929 performance options were forfeited. The Board of Directors authorized discretionary vesting for 995 performance options on August 15, 2026, and 995 options remained after the transaction.

Q: What are the TECH restricted stock unit vesting dates?

1,669 restricted stock units vest on each of August 15, 2026 and August 15, 2027. Another 2,332 restricted stock units vest on each of August 15, 2026, August 15, 2027 and August 15, 2028.

Some restricted stock unit vesting extends through August 15, 2028, under the stated award schedules.

Available on EDGAR 11/02/2026 - 04:35 PM EST Accepted by SEC EDGAR 11/02/2026 - 04:35 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

4/A

Rhea-AI Filing Summary

BIO-TECHNE Corp SVP - General Counsel Shane Bohnen reported acquiring 4,420 common shares on August 15, 2026, as restricted stock units vested. He also reported 1,366 shares delivered or withheld for payment of exercise price or tax liability at $72.40 per share. The transactions include forfeiture of 11,929 performance options and 4,432 performance RSUs; 995 performance options remained after the option transaction. The Board of Directors authorized discretionary vesting of 370 performance RSUs, and 49 restricted stock units vested.

Insider Trade Summary

4,420 shares exercised/converted

Exercise 8 txns

Insider Bohnen Shane

Role SVP - General Counsel

Type	Security	Shares	Price	Value
Disposition	Performance Stock Option (Right to Buy) ^F1	11,929	$0.00	$0.00
Exercise	Performance Restricted Stock Units ^{F2, F3}	370	$0.00	$0.00
Disposition	Performance Restricted Stock Units ^{F2, F3}	4,432	$0.00	$0.00
Exercise	Restricted Stock Units ^{F2, F4}	49	$0.00	$0.00
Exercise	Restricted Stock Units ^{F2, F5}	1,669	$0.00	$0.00
Exercise	Restricted Stock Units ^{F2, F6}	2,332	$0.00	$0.00
Exercise	Common Stock	4,420	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,366	$72.40	$99K

Holdings After Transaction: Performance Stock Option (Right to Buy) — 995 contracts (Direct); Performance Restricted Stock Units — 0 contracts (Direct); Restricted Stock Units — 6,333 contracts (Direct); Common Stock — 10,407 shares (Direct)

Footnotes (6)

F1. On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited.
F2. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3. On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited.
F4. 49 restricted stock units vest on 8/15/2026.
F5. 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
F6. 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.

Key Figures

Common shares acquired: 4,420 shares Shares delivered or withheld: 1,366 shares at $72.40 per share Performance options forfeited: 11,929 options +5 more

8 metrics

Common shares acquired 4,420 shares August 15, 2026

Shares delivered or withheld 1,366 shares at $72.40 per share For payment of exercise price or tax liability on August 15, 2026

Performance options forfeited 11,929 options August 15, 2026

Performance options remaining 995 options Following the option transaction

Performance RSUs forfeited 4,432 RSUs August 15, 2026

Performance RSUs authorized for discretionary vesting 370 RSUs Authorized by the Board of Directors on August 15, 2026

Restricted stock units vesting 1,669 RSUs on each of August 15, 2026 and August 15, 2027 Award vesting schedule

Restricted stock units vesting 2,332 RSUs on each of August 15, 2026, August 15, 2027 and August 15, 2028 Award vesting schedule

Key Terms

Performance Stock Option (Right to Buy), Performance Restricted Stock Units, contingent right to receive one share, discretionary vesting

4 terms

Performance Stock Option (Right to Buy) financial

"Performance Stock Option (Right to Buy)"

Performance Restricted Stock Units financial

"Performance Restricted Stock Units"

Performance restricted stock units (PRSUs) are promises to deliver company shares to employees or executives only if the business meets specific performance targets and any time-based holding rules. Think of them as a bonus that converts into stock only after set goals are reached, so investors watch PRSUs for two reasons: they can dilute existing shares if paid out, and they signal how closely management’s pay is tied to company performance.

discretionary vesting financial

"authorized discretionary vesting for 995 performance options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TECH shares did Shane Bohnen acquire?

Shane Bohnen acquired 4,420 common shares on August 15, 2026, as restricted stock units vested.

How many TECH shares did Shane Bohnen deliver or have withheld?

On August 15, 2026, 1,366 common shares were delivered or withheld for payment of exercise price or tax liability at $72.40 per share.

How many of Shane Bohnen’s performance options were forfeited?

11,929 performance options were forfeited. The Board of Directors authorized discretionary vesting for 995 performance options on August 15, 2026, and 995 options remained after the transaction.

What are the TECH restricted stock unit vesting dates?

1,669 restricted stock units vest on each of August 15, 2026 and August 15, 2027. Another 2,332 restricted stock units vest on each of August 15, 2026, August 15, 2027 and August 15, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bohnen Shane

(Last)

(First)

(Middle)

614 MCKINLEY PLACE NE

(Street)

MINNEAPOLIS

MINNESOTA

55413

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BIO-TECHNE Corp [ TECH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP - General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
08/18/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/15/2026		M		4,420	A	$0	11,773	D
Common Stock	08/15/2026		F		1,366	D	$72.4	10,407	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Stock Option (Right to Buy)	$84.61	08/15/2026		D			11,929	⁽¹⁾	⁽¹⁾	Common Stock	11,929	$0	995	D
Performance Restricted Stock Units	⁽²⁾	08/15/2026		M			370	⁽³⁾	⁽³⁾	Common Stock	370	$0	4,432	D
Performance Restricted Stock Units	⁽²⁾	08/15/2026		D			4,432	⁽³⁾	⁽³⁾	Common Stock	4,432	$0	0	D
Restricted Stock Units	⁽²⁾	08/15/2026		M			49	⁽⁴⁾	⁽⁴⁾	Common Stock	49	$0	0	D
Restricted Stock Units	⁽²⁾	08/15/2026		M			1,669	⁽⁵⁾	⁽⁵⁾	Common Stock	1,669	$0	1,669	D
Restricted Stock Units	⁽²⁾	08/15/2026		M			2,332	⁽⁶⁾	⁽⁶⁾	Common Stock	2,332	$0	4,664	D

Explanation of Responses:

1. On 8/15/2026, the Board of Directors authorized discretionary vesting for 995 performance options. The remainder of the performance options were forfeited.

2. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

3. On 8/15/2026, the Board of Directors authorized discretionary vesting for 370 performance RSUs. The remainder of the performance RSUs were forfeited.

4. 49 restricted stock units vest on 8/15/2026.

5. 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.

6. 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.

	/s/ Andrew Nick as Attorney-in-Fact for Shane Bohnen pursuant to Power of Attorney previously filed.	11/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR